 | | | | |
| |  | |  | | |
| |  |
| PRIME NEWS |  |
|
 |
|
|
Pharmaceutical companies Sosei and Vectura have announced the commencement of a phase III clinical study by Novartis, with NVA237.It was licensed to Novartis in April 2005 by Sosei and Vectura
|
|
|
|
|
|
|
|
|
Australian company, ChemGenex Pharmaceuticals has decided to seek a voluntary delisting from the NASDAQ Capital Market and to fully deregister from the US Securities and Exchange Commission's ongoing reporting obligations
|
|
|
|
|
|
|
 | | |
The latest pharmaceutical technology news, trends and analysis, pharma business and investment opportunities, pharmaceutical technology breakthroughs, launch and review of pharma, biopharma & pharmaceutical products, features, event listings and job postings.
| | | | |  | |  | | |
|
|
|
|
|
|
 |
|
 |
|
|
|
 |
FEATURES |
 |
|
|
|
Indonesia insists on local pharma production
|
|
| The government in Indonesia talks tough on pharma investors, creating a new rule that is aimed at bringing in foreign investment in the sector. The objective is to develop Indonesia as pharma manufacturing hub in South East Asia |
|
|
|
|
|
Merck's smart emerging market move
|
|
| The quest for growth in the emerging pharma markets of the world is driving the Big Pharma to look for suitable allies. So the consolidation wave continues, after the Pfizer-Wyeth merger, with another blockbuster $41.1 merger |
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
PEOPLE |
|
|
|
|
Avexa appoints new Director to Board
|
|
| Australian pharmaceutical company, Avexa has appointed Mr Lawrence Gozlan to its Board of Directors, replacing Dr John Sime who is retiring from the board |
|
|
|
|
|
Rockwell names Dr Ajay Gupta as CSO
|
|
| Dr Gupta will be responsible for the identification and development of new drug opportunities in the areas of women's health, oncology and parenteral nutrition as well as new drugs for other targeted renal therapies and indications |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EVENTS |
|
|
|
|
SUA to observe July as Prostate Awareness Month
|
|
| Singapore Urological Association (SUA) and Singapore Cancer Society are observing July as Prostate Awareness Month, starting from July 1 with an objective to call on men 50-75 years old to go for prostate health checks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R & D |
|
|
|
|
|
|
Glenmark's GRC 10693 completes phase I trials
|
|
| Glenmark Pharmaceuticals, a research-driven, global, integrated pharmaceutical company announced that its candidate for neuropathic pain, osteoarthritis and other inflammatory pain disorders GRC 10693 has successfully completed phase I trials |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POLICIES |
|
|
|
|
|
|
FDA approves Ilaris to treat rare disease CAPS
|
|
| The FDA has approved Ilaris (canakinumab) for the treatment of children and adults with cryopyrin-associated periodic syndrome (CAPS), which includes a number of rare but life-long auto-inflammatory disorders with debilitating symptoms |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PRODUCTS |
|
|
|
|
Lupin acquires worldwide rights for AllerNaze
|
|
| Indian pharmaceutical major, Lupin has acquired worldwide rights for the intra-nasal steroid (INS) product, AllerNaze (triamcinolone acetonide, USP) Nasal Spray, 50mcg from Collegium Pharmaceutical |
|
|
|
|
|
Dr Reddy's launches Bispec in India
|
|
| According to the company, Bispecm is the best-in-class for the management of Over Active Bladder (OAB) and has lesser incidence of dry mouth and constipation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|  | |  | | | | |  | |  |
|
|
|
| | | | | | | | |
